ArticleBlood cancer journal2015

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes.

K L McGraw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.